68 related articles for article (PubMed ID: 3433763)
1. [Treatment of patients with advanced breast cancer with increased doses of methotrexate and orally administered calcium folate].
Pawlicki M; Zuchowska-Vogelgesang B; Rolski J; Kurek S; Kowalczyk J
Wiad Lek; 1987 Jul; 40(14):951-6. PubMed ID: 3433763
[No Abstract] [Full Text] [Related]
2. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
3. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma.
Sandri MT; Johansson H; Colleoni M; Zorzino L; Passerini R; Orlando L; Viale G
Anticancer Res; 2004; 24(2C):1261-6. PubMed ID: 15154657
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative polychemotherapy in the overall treatment of locally spread breast cancer (immediate results)].
Sokolova IG; Vishniakova EG; Sviatukhina OV
Vopr Onkol; 1980; 26(5):9-13. PubMed ID: 7385720
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
8. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
10. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
11. Melphalan and methotrexate in advanced breast cancer.
Priestman TJ; Salaman PF
Cancer Treat Rep; 1978 Dec; 62(12):2111-2. PubMed ID: 751718
[No Abstract] [Full Text] [Related]
12. A pilot study of a high dose methotrexate regime in the management of advanced breast cancer.
Penney GC; Roberts MM
Clin Oncol; 1980 Dec; 6(4):385-6. PubMed ID: 7460412
[No Abstract] [Full Text] [Related]
13. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Rabinovich MG; Leone BA; Landó O
Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
[No Abstract] [Full Text] [Related]
15. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
Tisman G; Wu SJ
Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
18. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
[TBL] [Abstract][Full Text] [Related]
19. [Methotrexate and folates in rheumatoid arthritis].
Endresen GK; Husby G
Tidsskr Nor Laegeforen; 1999 Feb; 119(4):534-7. PubMed ID: 10081378
[TBL] [Abstract][Full Text] [Related]
20. [Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Ito T; Yamada M; Tanemura H; Oshita H; Asano M; Saji S
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1575-80. PubMed ID: 9725051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
